Exploring the complexity, treatment challenges, and outcomes in pediatric nodular lymphocyte predominant Hodgkin lymphoma: a perspective from a low–middle-income country
Pediatric patients with early-stage NLPHL have an excellent prognosis, with a 5-year OS of 100%. However, those with advanced stages had a high relapse rate. R-CHOP was associated with a better response and relapse-free rate than ABVD.
Authors
- Engy Mohammed
- Marwa Romeih (ORCID: https://orcid.org/0000-0003-2099-0577)
- Youssef Madney (ORCID: https://orcid.org/0000-0003-0511-1562)
- Mohamed S. Zaghloul (ORCID: https://orcid.org/0000-0002-1999-6528)
- Eman A. Attia
- Soha Ahmed (ORCID: https://orcid.org/0000-0003-2450-0563)
- Amr Abdalla
- Sally Fikry
- Hala Taha (ORCID: https://orcid.org/0000-0001-8068-9431)
Institutions
- Suez University (EG)
- Cairo University (EG)
- Children Cancer Hospital (EG)
- Sultan Qaboos University (OM)
- Helwan University (EG)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2024-10-25
- DOI
- https://doi.org/10.3389/fonc.2024.1432650
- Citations
- 4
- Primary Topic
- Lymphoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.70